Verona Pharma plc (VRNA) Tops Q3 EPS by 1c

Verona Pharma plc (NASDAQ: VRNA) reported Q3 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results